Funding for this research was provided by:
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-14-1-0089)
United States Department of Defense | Defense Advanced Research Projects Agency (HR001117C0095)
Article History
Received: 27 September 2022
Accepted: 13 April 2023
First Online: 27 April 2023
Competing interests
: A.U.S. patent application was filed on December 21, 2022, on protein-sensing riboswitches (application No. 63/434,212 assigned to Penn State University). H.M.S. is also a founder of De Novo DNA. G.E.V. and L.R.G. declare no competing interests.